Quest Gets FDA Emergency Approval For New Lab Method To Improve Coronavirus Testing Capacity, Speed
Quest Diagnostics Inc (NYSE: DGX) announced Wednesday it had received an emergency use authorization from the Food and Drug Administration for a new laboratory technique that can help signficantly expand and speed up novel coronavirus (COVID-19) testing.
